Pirenzepine-d8

Pirenzepine-d8 Struktur
1189944-02-2
CAS-Nr.
1189944-02-2
Englisch Name:
Pirenzepine-d8
Synonyma:
Tabe-d;Tabe-d8;Maghen-d8;Leblon-d8;Renzepin-d8;Gasteril-d8;Durapirenz-d8;Duogastral-d8;Pirenzepine-d8;Gastrozepin-d8
CBNumber:
CB71176682
Summenformel:
C19H21N5O2
Molgewicht:
351.40234
MOL-Datei:
1189944-02-2.mol

Pirenzepine-d8 Eigenschaften

Sicherheit

Pirenzepine-d8 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

An antiulcerative. Tricyclic gastric-acid inhibitor

Pirenzepine-d8 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Pirenzepine-d8 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 96815 76
Chemsky (shanghai) International Co.,Ltd 021-50135380
shchemsky@sina.com China 15421 60
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 13028896684
sales@rrkchem.com China 56057 58
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44843 58
Nanjing Shizhou Biology Technology Co.,Ltd 17301488900
judy.xia@synzest.com China 12584 58

  • 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl-d8)acetyl]- 6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
  • Duogastral-d8
  • Durapirenz-d8
  • Gasteril-d8
  • Gastrozepin-d8
  • Leblon-d8
  • Maghen-d8
  • Pirenzepine-d8
  • Renzepin-d8
  • Tabe-d
  • 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl-d8)acetyl]-6H-pyrido[2,3-β][1,4]benzodiazepin-6-one
  • Tabe-d8
  • 11-[2-(2,2,3,3,5,5,6,6-octadeuterio-4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
  • Pirenzepine D8 DihydrochlorideQ: What is Pirenzepine D8 Dihydrochloride Q: What is the CAS Number of Pirenzepine D8 Dihydrochloride
  • 1189944-02-2
  • C19H13D8N5O2
  • Inhibitor
  • Intermediates & Fine Chemicals
  • Isotope Labeled Compounds
  • Pharmaceuticals
  • Isotope Labelled Compounds
  • All Inhibitors
Copyright 2019 © ChemicalBook. All rights reserved